Agilent Advanced Therapeutics is Agilent’s specialty CDMO, delivering customized development and manufacturing solutions for advanced therapeutics from development through commercial supply. Combining deep scientific expertise, flexible manufacturing, and white-glove partnership, we help innovators move programs forward with confidence.
Our capabilities include:
Agilent Advanced Therapeutics brings together BIOVECTRA’s expertise in biologics fermentation, complex chemistry, highly potent APIs, and bioreagents with Agilent’s Nucleic Acid Solutions Division capabilities in advanced nucleic acid manufacturing.
Schedule a meeting with us and discover how we can support your projects and solve your most complex challenges.